July 29, 2019
Rainier Therapeutics Announces Vofatamab FIERCE-22 Data Accepted for Presentation at ESMO 2019 Annual Congress
Media
July 25, 2019
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report
July 25, 2019
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report
July 24, 2019
GenSight Biologics Reports Interim Financial Results for the First Half of 2019 and Provides Operational Update
July 23, 2019
MIPS INTERIM REPORT JANUARY – JUNE 2019
July 16, 2019
Targovax announces start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies
July 12, 2019
GenSight Biologics completes enrollment of GS010 REFLECT Phase III trial in the treatment of Leber Hereditary Optic Neuropathy ahead of schedule
July 11, 2019
Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in diffuse large B-cell lymphoma (DLBCL)
July 11, 2019
Orexo Interim Report Q2 2019
July 10, 2019
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio